Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04711161
Title First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Green3Bio, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.